
Biopharmaceutical Analytical Testing Services is a workflow for identifying and quantifying host cell protein-related impurities in pharmaceutical products, separate therapeutic and diagnostic oligonucleotides and their derivatives, and validated structural protein comparative analysis for biosimilar development the process of.
Highlights
The global Biopharmaceutical Analytical Testing Services market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Biopharmaceutical Analytical Testing Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Biopharmaceutical Analytical Testing Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Biopharmaceutical Analytical Testing Services in Laboratory is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Biopharmaceutical Analytical Testing Services include Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific, Intertek Group, Merck KGaA, SGS SA, Solvias AG and STERIS, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Analytical Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Analytical Testing Services.
The Biopharmaceutical Analytical Testing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biopharmaceutical Analytical Testing Services market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Analytical Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Boston Analytical
Catalent Inc.
Charles River Laboratories International Inc.
Eurofins Scientific
Intertek Group
Merck KGaA
SGS SA
Solvias AG
STERIS
West Pharmaceutical Services Inc.
Segment by Type
Test Suite
Testing Services
Testing Software
Other
Segment by Application
Laboratory
Research Institutions
Pharmaceutical Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical Analytical Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Test Suite
1.2.3 Testing Services
1.2.4 Testing Software
1.2.5 Other
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Laboratory
1.3.3 Research Institutions
1.3.4 Pharmaceutical Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Biopharmaceutical Analytical Testing Services Growth Trends by Region
2.2.1 Global Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biopharmaceutical Analytical Testing Services Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Biopharmaceutical Analytical Testing Services Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Dynamics
2.3.1 Biopharmaceutical Analytical Testing Services Industry Trends
2.3.2 Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Drivers
2.3.3 Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Challenges
2.3.4 Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Analytical Testing Services Players by Revenue
3.1.1 Global Top Biopharmaceutical Analytical Testing Services Players by Revenue (2018-2023)
3.1.2 Global Biopharmaceutical Analytical Testing Services Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Analytical Testing Services Revenue
3.4 Global Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Analytical Testing Services Revenue in 2022
3.5 Biopharmaceutical Analytical Testing Services Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Analytical Testing Services Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Analytical Testing Services Breakdown Data by Type
4.1 Global Biopharmaceutical Analytical Testing Services Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Biopharmaceutical Analytical Testing Services Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Biopharmaceutical Analytical Testing Services Breakdown Data by Application
5.1 Global Biopharmaceutical Analytical Testing Services Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Biopharmaceutical Analytical Testing Services Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Biopharmaceutical Analytical Testing Services Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Analytical
11.1.1 Boston Analytical Company Detail
11.1.2 Boston Analytical Business Overview
11.1.3 Boston Analytical Biopharmaceutical Analytical Testing Services Introduction
11.1.4 Boston Analytical Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.1.5 Boston Analytical Recent Development
11.2 Catalent Inc.
11.2.1 Catalent Inc. Company Detail
11.2.2 Catalent Inc. Business Overview
11.2.3 Catalent Inc. Biopharmaceutical Analytical Testing Services Introduction
11.2.4 Catalent Inc. Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.2.5 Catalent Inc. Recent Development
11.3 Charles River Laboratories International Inc.
11.3.1 Charles River Laboratories International Inc. Company Detail
11.3.2 Charles River Laboratories International Inc. Business Overview
11.3.3 Charles River Laboratories International Inc. Biopharmaceutical Analytical Testing Services Introduction
11.3.4 Charles River Laboratories International Inc. Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.3.5 Charles River Laboratories International Inc. Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Biopharmaceutical Analytical Testing Services Introduction
11.4.4 Eurofins Scientific Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.4.5 Eurofins Scientific Recent Development
11.5 Intertek Group
11.5.1 Intertek Group Company Detail
11.5.2 Intertek Group Business Overview
11.5.3 Intertek Group Biopharmaceutical Analytical Testing Services Introduction
11.5.4 Intertek Group Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.5.5 Intertek Group Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Biopharmaceutical Analytical Testing Services Introduction
11.6.4 Merck KGaA Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.6.5 Merck KGaA Recent Development
11.7 SGS SA
11.7.1 SGS SA Company Detail
11.7.2 SGS SA Business Overview
11.7.3 SGS SA Biopharmaceutical Analytical Testing Services Introduction
11.7.4 SGS SA Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.7.5 SGS SA Recent Development
11.8 Solvias AG
11.8.1 Solvias AG Company Detail
11.8.2 Solvias AG Business Overview
11.8.3 Solvias AG Biopharmaceutical Analytical Testing Services Introduction
11.8.4 Solvias AG Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.8.5 Solvias AG Recent Development
11.9 STERIS
11.9.1 STERIS Company Detail
11.9.2 STERIS Business Overview
11.9.3 STERIS Biopharmaceutical Analytical Testing Services Introduction
11.9.4 STERIS Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.9.5 STERIS Recent Development
11.10 West Pharmaceutical Services Inc.
11.10.1 West Pharmaceutical Services Inc. Company Detail
11.10.2 West Pharmaceutical Services Inc. Business Overview
11.10.3 West Pharmaceutical Services Inc. Biopharmaceutical Analytical Testing Services Introduction
11.10.4 West Pharmaceutical Services Inc. Revenue in Biopharmaceutical Analytical Testing Services Business (2018-2023)
11.10.5 West Pharmaceutical Services Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Boston Analytical
Catalent Inc.
Charles River Laboratories International Inc.
Eurofins Scientific
Intertek Group
Merck KGaA
SGS SA
Solvias AG
STERIS
West Pharmaceutical Services Inc.
Ìý
Ìý
*If Applicable.
